Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis

Summary

This two cohort study (Cohort A and B) is being conducted to assess the safety and efficacy of BBI-2000 for the prevention (Cohort A) and treatment (Cohort B) of delayed type hypersensitivity reaction.

Timeline

Start

2017-03-14

Primary completion

2017-05-24

Completion

2017-05-24

Drugs

Indications